Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.380 | None | 1.000 | 3 | 0 | 2001 | 2019 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2008 | 2015 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2004 | 2007 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2007 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.200 | None | 0.923 | 2 | 0 | 1996 | 2017 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.150 | None | 1.000 | 2 | 0 | 1996 | 2016 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 1997 | 2020 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.080 | None | 0.875 | 2 | 0 | 1998 | 2004 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.060 | None | 1.000 | 2 | 0 | 1997 | 2017 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.060 | None | 0.833 | 2 | 0 | 2004 | 2019 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.050 | None | 1.000 | 2 | 0 | 1999 | 2008 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
phenotype | 0.050 | None | 1.000 | 2 | 0 | 2003 | 2015 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2002 | 2005 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
group | 0.040 | None | 1.000 | 3 | 0 | 2000 | 2007 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
group | 0.040 | None | 1.000 | 3 | 0 | 1999 | 2007 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2000 | 2017 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
group | 0.040 | None | 1.000 | 1 | 0 | 1997 | 2015 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2008 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2000 | 2008 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2001 | 2005 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2002 | 2006 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 1996 | 2004 |